Boiron : Projected timetable of the next publications and events 2017/2018
June 16, 2017 at 06:40 am EDT
Share
June 15, 2017
Projected timetable
of the next publications and events 2017/2018
The projected timetable of the next publications and events for the rest of the year 2017 and for the year 2018 is the following one:
Publications
Date of publication (after market closing)
Information meetings
Half-year sales of 2017
Quiet period from Wednesday, July 5, 2017
Thursday, July 20, 2017
Half-year results of 2017
Quiet period from Friday, July 21, 2017
Thursday, September 7, 2017
Friday, September 8, 2017 at 10:00 am at the SFAF
3rdquarter sales of 2017
Quiet period from Wednesday, October 4, 2017
Thursday, October 19, 2017
Annual sales of 2017
Quiet period from Wednesday, January 10, 2018
Thursday, January 25, 2018
Annual results of 2017
Quiet period from Monday, February 12, 2018
Wednesday, March 14, 2018
Thursday, March 15, 2018 at 2:30 pm at the SFAF
1stquarter sales of 2018
Quiet period from Wednesday,April 11, 2018
Thursday, April 26, 2018
Shareholders' Meeting 2018
Thursday, May 17, 2018
Half-year sales of 2018
Quiet period from Wednesday, July 4, 2018
Thursday, July 19, 2018
Half-year results of 2018
Quiet period from Friday, July 20, 2018
Wednesday, September 5, 2018
Thursday, September 6, 2018 at 2:30 pm at the SFAF
3rdquarter sales of 2018
Quiet period from Wednesday, October 3, 2018
Thursday, October 18, 2018
Quiet period: during the period prior to the publications, BOIRON limits its communication with the financial community.
Our next update:
July 20, 2017: after the close of the stock market, publication of the sales on June 30, 2017. Person responsible for financial information: Christian Boiron.
Contact for financial information: Véronique Bouscayrol.
Investor relations +33 (0) 4.78.45.63.43 - e-mail:boironfinances@boiron.frISIN code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA The group's financial information is online at: www.boironfinance.com
Boiron SA published this content on 16 June 2017 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 16 June 2017 10:40:05 UTC.
Public permalinkhttp://www.publicnow.com/view/D2FEFBE2917FE60008CF6FBAB5C83D8071F93E5A
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues.
Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin.
There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties).
BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries.
Net sales are distributed geographically as follows: France (52.4%), Europe (22.5%), North America (22.6%) and other (2.5%).
BOIRON 
